UCB S.A.
General ticker "UCBJF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $40.5B (TTM average)
UCB S.A. follows the US Stock Market performance with the rate: 47.5%.
Estimated limits based on current volatility of 3.0%: low 283.59$, high 301.23$
Factors to consider:
- Company pays dividends (annually): last record date 2025-04-28, amount 1.58$ (Y0.56%)
Short-term UCBJF quotes
Long-term UCBJF plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | €6,152.00MM | €7,738.10MM |
| Operating Expenses | €4,828.00MM | €5,729.85MM |
| Operating Income | €1,324.00MM | €2,008.25MM |
| Non-Operating Income | €-161.00MM | €-186.93MM |
| Interest Expense | €164.60MM | €125.95MM |
| R&D Expense | €1,781.00MM | €1,821.32MM |
| Income(Loss) | €1,163.00MM | €1,821.32MM |
| Taxes | €98.00MM | €263.90MM |
| Profit(Loss)* | €1,065.00MM | €1,557.42MM |
| Stockholders Equity | €10,029.00MM | €10,862.93MM |
| Inventory | €1,309.00MM | €1,495.44MM |
| Assets | €17,347.00MM | €18,151.20MM |
| Operating Cash Flow | €1,242.00MM | €2,162.19MM |
| Capital expenditure | €322.00MM | €280.89MM |
| Investing Cash Flow | €282.00MM | €-388.85MM |
| Financing Cash Flow | €-818.00MM | €-1,085.59MM |
| Earnings Per Share** | €5.61 | €8.20 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.